Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity

Katrin M. Baltz, Matthias Krusch, Tina Baessler, Benjamin J. Schmiedel, Anita Bringmann, Peter Brossart, Helmut R. Salih

Blood (2008) 112 (9): 3735–3743.

https://doi.org/10.1182/blood-2008-03-143016

Published: 2008

Includes: Supplemental data

Journal Articles

Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.

Mercedes Kloss, Patrice Decker, PhD, Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Lothar Kanz, MD, Alexander Steinle, PhD, Helmut R. Salih, MD

Blood (2007) 110 (11): 2415.

https://doi.org/10.1182/blood.V110.11.2415.2415

Published: 2007

Journal Articles

Role of Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand in the Interaction of Acute Myeloid Leukemia with NK Cells.

Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 18.

https://doi.org/10.1182/blood.V110.11.18.18

Published: 2007

Journal Articles

Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.

Katrin M. Baltz, Matthias Krusch, MD, Tina Baessler, Anita Bringmann, Lothar Kanz, MD, Peter Brossart, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 314.

https://doi.org/10.1182/blood.V110.11.314.314

Published: 2007

Journal Articles

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Matthias Krusch, MD, Sorin Armeanu, PhD, Katrin M. Baltz, Ulrich M. Lauer, MD, Alexander Steinle, PhD, Lothar Kanz, MD, Michael Bitzer, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 4181.

https://doi.org/10.1182/blood.V110.11.4181.4181

Published: 2007

Journal Articles

Role of CD137/4-1BB and Its Ligand in the NK Cell Mediated Immune Surveillance of Acute Myeloid Leukemia.

Tina Baessler, Matthias Krusch, MD, Katrin M. Baltz, Benjamin J. Schmiedel, Helga M. Schmetzer, PhD, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 880.

https://doi.org/10.1182/blood.V110.11.880.880

Published: 2007

Journal Articles

Expression of Glucocorticoid-Induced TNF Receptor Ligand on Acute Myeloid Leukemia Cells Mediates the Release of Immunosuppressive Cytokines and Impairs NK Cell-Mediated Immune Surveillance.

Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Mercedes Kloss, Ingrid Kumbier, Andrea Peterfi, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2006) 108 (11): 1941.

https://doi.org/10.1182/blood.V108.11.1941.1941

Published: 2006

Journal Articles

The Ligand of Glucocorticoid-Induced TNF Receptor Is Expressed on Human Macrophages and Stimulates Proinflammatory and Anti-Tumor Effector Functions.

Mercedes Kloss, Matthias Krusch, MD, Katrin M. Baltz, Andrea Peterfi, Ingrid Kumbier, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2006) 108 (11): 1649.

https://doi.org/10.1182/blood.V108.11.1649.1649

Published: 2006

Journal Articles

Down-Regulation of Glucocorticoid-Induced TNF Receptor (GITR) Ligand on Human Tumors by Proteolytic Shedding Increases Anti-Tumor Reactivity of NK Cells.

Katrin M. Baltz, Matthias Krusch, MD, Tina Baessler, Mercedes Kloss, Ingrid Kumbier, Andrea Peterfi, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2006) 108 (11): 926.

https://doi.org/10.1182/blood.V108.11.926.926

Published: 2006

Journal Articles

Human GITR Ligand Is Expressed on Tumor Cells and Reduces Cytokine Production and Cellular Cytotoxicity of NK Cells Identified to Express GITR.

Katrin M. Baltz, Matthias Krusch, Radsak P. Markus, MD, Frank Mayer, MD, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2005) 106 (11): 3310.

https://doi.org/10.1182/blood.V106.11.3310.3310

Published: 2005

NARROW

Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity

Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.

Role of Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand in the Interaction of Acute Myeloid Leukemia with NK Cells.

Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Role of CD137/4-1BB and Its Ligand in the NK Cell Mediated Immune Surveillance of Acute Myeloid Leukemia.

Expression of Glucocorticoid-Induced TNF Receptor Ligand on Acute Myeloid Leukemia Cells Mediates the Release of Immunosuppressive Cytokines and Impairs NK Cell-Mediated Immune Surveillance.

The Ligand of Glucocorticoid-Induced TNF Receptor Is Expressed on Human Macrophages and Stimulates Proinflammatory and Anti-Tumor Effector Functions.

Down-Regulation of Glucocorticoid-Induced TNF Receptor (GITR) Ligand on Human Tumors by Proteolytic Shedding Increases Anti-Tumor Reactivity of NK Cells.

Human GITR Ligand Is Expressed on Tumor Cells and Reduces Cytokine Production and Cellular Cytotoxicity of NK Cells Identified to Express GITR.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only